Rockwell Medical, Inc.
RMTI
$0.8228
$0.00460.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -100.40% | -145.43% | 385.13% | 119.82% | -14.48% |
| Total Depreciation and Amortization | -0.74% | 0.00% | -1.09% | 0.73% | -0.91% |
| Total Amortization of Deferred Charges | -1.12% | 1.14% | 193.33% | -86.30% | -73.65% |
| Total Other Non-Cash Items | 15.75% | -13.68% | 60.79% | -7.92% | 28.76% |
| Change in Net Operating Assets | -74,860.00% | -99.40% | 544.44% | 91.34% | -328.04% |
| Cash from Operations | -503.12% | -79.77% | 196.46% | 160.59% | -5,434.88% |
| Capital Expenditure | 84.05% | -106.81% | 33.22% | -105.76% | -223.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.59% | 101.06% | -395.61% | -- | -- |
| Cash from Investing | 99.70% | 94.57% | -455.97% | 1,335.25% | -106.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.17% | -0.59% | -147.10% | 63.87% | 79.66% |
| Issuance of Common Stock | -- | 4.35% | 64.78% | 293.39% | -49.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 33.23% | 33.09% | -- | -- | -- |
| Cash from Financing | -128.04% | 20.71% | 12.01% | 1,060.11% | 123.99% |
| Foreign Exchange rate Adjustments | -- | 0.00% | 66.67% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -228.49% | 599.79% | -90.90% | 323.02% | -291.26% |